Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.3 is now displayed, replacing Revision: v3.5.2 on the page. This indicates a software update to the underlying component, with no changes to study content.
    Difference
    0.1%
    Check dated 2026-04-30T18:43:52.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a new revision tag 'Revision: v3.5.2' and removed the older tag 'Revision: v3.5.0'.
    Difference
    0.1%
    Check dated 2026-04-16T10:49:47.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a new publication to the Publications section: Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis. Lancet Oncol. 2024 Nov;25(11):1465-1475.
    Difference
    0.1%
    Check dated 2026-04-02T01:37:43.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Hepatocellular carcinoma has been added as the condition and the Genetic and Rare Diseases Information Center has been added to the resources. The page revision has been updated to v3.5.0 (replacing v3.4.3).
    Difference
    0.2%
    Check dated 2026-03-18T18:05:36.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:51:32.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added a new revision tag (Revision: v3.4.2). Removed an operational status notice about government funding, while the study details and status remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T02:33:13.000Z thumbnail image

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.